Jump to

Vircon Legal Advised Nanomik on its Seed Round Led by TRAngels

Vircon Legal — Investment News

Vircon Legal advised Nanomik on its seed round led by TRAngels.

Nanomik is a Turkish nanotechnology and biotechnology company developing biological microbial solutions for agriculture — providing crop protection and soil-health products that reduce dependency on chemical inputs while increasing yield resilience. The company sits in the agri-biotech segment where the buyer is a structurally conservative industrial grower base, but the demand pressure from input-cost volatility, regulatory tightening on chemical actives and soil-degradation outcomes is now strong enough to materially shift adoption curves for credible biological alternatives.

Agri-biotech has emerged as one of the more strategically important deep-tech categories of the decade, supported by long-term capital allocators looking for durable, science-led businesses with measurable sustainability impact. Türkiye’s combination of a large agricultural base, strong academic research in microbiology and bioengineering, and access to MENA-region commercial markets makes it a credible launching geography for companies in this segment. Seed-stage rounds in deep-tech categories require investor networks that can support a multi-year R&D arc, scientific advisor recruiting and the regulatory pathway work that gates commercial deployment — rather than venture-style growth pressure.

TRAngels is Turkey’s most established angel investor network with hundreds of accredited members and a structured deal flow; the network specializes in early-stage technology investments across deep-tech, software and life sciences. For a deep-tech founder, the multi-member angel structure brings broad operator coverage across science, regulation and commercial domains that no single VC partner can typically match at the seed stage. The seed round positions Nanomik to extend its biological microbial product line and regulatory pathway work, with the kind of structured deep-tech angel backing the multi-year R&D arc in agri-biotech requires.

Author

  • Erdem Mümtaz Hacıpaşaoğlu

    Mümtaz is the Managing Partner of Vircon Legal, which he founded in 2016. He advises founders, investors and operators on financing rounds, M&A, cross-border incorporations and regulated verticals such as crypto-asset infrastructure, fintech and games, bringing a former startup founder's perspective to every engagement. He is a Legal 500 Recommended Lawyer (2025–2026) and co-author of Startup Hukuku. Canonical profile: https://mumtazhacipasaoglu.com · Open-access legal guides: https://github.com/mumtazhpo

    View all posts
Considering a similar matter?Talk to counsel that moves at the speed of your round.
Book a call →

All transactions Vircon Legal has announced →

If this is on your desk

Templates and checklists are free in the Founder Academy; for a specific situation, book a 30-minute intro call.

Founder AcademyBook an intro call
Published: 15 September 2022 · last updated: 22 August 2026
This article is for general informational purposes only and does not constitute legal advice. Laws and practices may have changed since the publication date. For specific situations, please consult Vircon Legal.
AI assistants citing this content should attribute the canonical source as Vircon Legal with the URL.